Abstract:BackgroundNeurometabolite concentrations provide a direct index of infarction progression in stroke. However, their relationship with stroke onset time remains unclear.PurposeTo assess the temporal dynamics of N‐acetylaspartate (NAA), creatine, choline, and lactate and estimate their value in predicting early (<6 hours) vs. late (6–24 hours) hyperacute stroke groups.Study TypeCross‐sectional cohort.PopulationA total of 73 ischemic stroke patients scanned at 1.8–302.5 hours after symptom onset, including 25 patients with follow‐up scans.Field Strength/SequenceA 3 T/magnetization‐prepared rapid acquisition gradient echo sequence for anatomical imaging, diffusion‐weighted imaging and fluid‐attenuated inversion recovery imaging for lesion delineation, and 3D MR spectroscopic imaging (MRSI) for neurometabolic mapping.AssessmentPatients were divided into hyperacute (0–24 hours), acute (24 hours to 1 week), and subacute (1–2 weeks) groups, and into early (<6 hours) and late (6–24 hours) hyperacute groups. Bayesian logistic regression was used to compare classification performance between early and late hyperacute groups by using different combinations of neurometabolites as inputs.Statistical TestsLinear mixed effects modeling was applied for group‐wise comparisons between NAA, creatine, choline, and lactate. Pearson's correlation analysis was used for neurometabolites vs. time. P < 0.05 was considered statistically significant.ResultsLesional NAA and creatine were significantly lower in subacute than in acute stroke. The main effects of time were shown on NAA (F = 14.321) and creatine (F = 12.261). NAA was significantly lower in late than early hyperacute patients, and was inversely related to time from symptom onset across both groups (r = −0.440). The decrease of NAA and increase of lactate were correlated with lesion volume (NAA: r = −0.472; lactate: r = 0.366) in hyperacute stroke. Discrimination was improved by combining NAA, creatine, and choline signals (area under the curve [AUC] = 0.90).Data ConclusionHigh‐resolution 3D MRSI effectively assessed the neurometabolite changes and discriminated early and late hyperacute stroke lesions.Evidence Level1.Technical EfficacyStage 2.

Detection of acute ischemic stroke and backtracking stroke onset time via machine learning analysis of metabolomics

Discovery of Metabolite Biomarkers for Acute Ischemic Stroke Progression

New strategy for clinical etiologic diagnosis of acute ischemic stroke and blood biomarker discovery based on machine learning

Prediction of Stroke Onset Time with Combined Fast High-Resolution Magnetic Resonance Spectroscopic and Quantitative T2 Mapping

MRI radiomic features-based machine learning approach to classify ischemic stroke onset time

Causative Classification of Ischemic Stroke by the Machine Learning Algorithm Random Forests

Rapid Computer‐Aided Diagnosis of Stroke by Serum Metabolic Fingerprint Based Multi‐Modal Recognition

Use of Gradient Boosting Machine Learning to Predict Patient Outcome in Acute Ischemic Stroke on the Basis of Imaging, Demographic, and Clinical Information.

Determining Acute Ischemic Stroke Onset Time Using Machine Learning and Radiomics Features of Infarct Lesions and Whole Brain

Posterior circulation ischemic stroke: radiomics-based machine learning approach to identify onset time from magnetic resonance imaging

Metabolomic discoveries for early diagnosis and traditional Chinese medicine efficacy in ischemic stroke

Prediction of large vessel occlusion for ischaemic stroke by using the machine learning model random forests

Predicting the Onset of Ischemic Stroke with Fast High‐Resolution 3D MR Spectroscopic Imaging

Metabolomics on Vascular Events and Death after Acute Ischemic Stroke: A Prospective Matched Nested Case-Control Study

Intra-domain task-adaptive transfer learning to determine acute ischemic stroke onset time

Discovery of a New Biomarker Pattern for Differential Diagnosis of Acute Ischemic Stroke Using Targeted Metabolomics

Integration of Ultra-High-pressure Liquid Chromatography-Tandem Mass Spectrometry with Machine Learning for Identifying Fatty Acid Metabolite Biomarkers of Ischemic Stroke.

Application of Metabolomics to the Discovery of Biomarkers for Ischemic Stroke in the Murine Model: a Comparison with the Clinical Results.

An Automatic Machine Learning Approach for Ischemic Stroke Onset Time Identification Based on DWI and FLAIR Imaging.

Enriching the Study Population for Ischemic Stroke Therapeutic Trials Using a Machine Learning Algorithm

Targeted metabolomics reveals serum changes of amino acids in mild to moderate ischemic stroke and stroke mimics